3334-66-5

Usage

Uses

Used in Pharmaceutical Research:
3-AMINO-3-(2-METHOXYPHENYL)PROPIONIC ACID is used as a building block for the synthesis of various drug candidates and prodrugs. Its unique structure allows for the development of new therapeutic agents with potential applications in treating pain, inflammation, and neurological disorders.
Used in Treatment of Pain and Inflammation:
3-AMINO-3-(2-METHOXYPHENYL)PROPIONIC ACID is used as a therapeutic agent for the treatment of pain and inflammation. Its chemical structure enables it to modulate biological pathways involved in these conditions, providing potential relief and management for patients suffering from such ailments.
Used in Neurological Disorders Treatment:
3-AMINO-3-(2-METHOXYPHENYL)PROPIONIC ACID is also being investigated for its potential therapeutic applications in the treatment of neurological disorders. Its unique properties may contribute to the development of new treatments for conditions such as epilepsy, Alzheimer's disease, and Parkinson's disease.
Used in Development of New Materials and Chemical Processes:
3-AMINO-3-(2-METHOXYPHENYL)PROPIONIC ACID has been studied for its potential use in the development of new materials and chemical processes. Its versatile chemical structure allows for its incorporation into various applications, potentially leading to advancements in material science and chemical engineering.

InChI:InChI=1/C10H13NO3/c1-14-9-5-3-2-4-8(9)11-7-6-10(12)13/h2-5,11H,6-7H2,1H3,(H,12,13)/p-1

Upstream product

• 23947-29-7 methyl 3-[(2-methoxyphenyl)amino]propanoate 
• 90-04-0 2-methoxy-phenylamine 

Downstream Products

• 3835-23-2 1,2,3,4-tetrahydro-8-methoxyquinolin-4-one 

Relevant academic research and scientific papers

2,3-dihydro-1H-quinoline-4-ketone thiosemicarbazone derivatives as well as preparation method and application thereof

The invention discloses 2,3-dihydro-1H-quinoline-4-ketone thiosemicarbazone derivatives as well as a preparation method and application thereof. The structural formula of the derivatives is as shown in a formula (I): (the formula is as shown in the description), wherein R1 is halogen, alkyl or alkoxy; R2 is hydrogen, halogen or alkoxy; R3 is hydrogen or halogen; R4 is hydrogen or halogen; X is hydrogen, acetyl or nitryl; and Y is hydrogen or phenyl. The derivatives can obviously inhibit proliferation of tumor cells, and has significant inhibition effect on multiple cancer cell strains such asbreast cancer cells, melanoma cells and prostatic cancer cells; and the anti-tumor activity is obviously better than that of a broad-spectrum anti-cancer medicine cis-platinum. In addition, the preparation process of the derivatives is simple, the conditions are mild, the sources of the raw materials are rich, the production cost is low, and potential medicinal value and good application prospectin the aspect of preparing a novel anti-tumor medicine are achieved.

ANTIVIRAL COMPOUNDS

The present invention relates to novel compounds of general formula (I) wherein the groups X, and R1 to R4 have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.

A regioselective synthesis of tetrahydrobenzodiazepin-5-ones via the Schmidt rearrangement of quinolones

The regioselective synthesis of 2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-5- ones by the Schmidt rearrangement of 1,2,3,4-tetrahydro-4-quinolones with oxygen substituents at C-8 is described.